To learn about other cannabinoids go to our Cannabinoid Dictionary page.
Cannabidivarin, or CBDV, is very similar to CBD in both structure and it’s non-psychoactive effects. CBDV has been found to have anticonvulsant effects. It was identified for the first time in 1969 by Vollner et al. This cannabinoid occurs naturally in both the hemp and cannabis plants. Because it is derived from CBD, CBDV is most likely non-psychoactive, meaning it will not get you high or impair your mental processes.
While some of the other CBD derivatives are more recent discoveries, CBDV was originally discovered over 50 years ago, back in 1969.
It can only be found in minute amounts in hemp and cannabis plants, which makes isolating it for research purposes a more difficult task. For this reason, and a few others, studies into the effects of CBDV are minimal.
CBDV is one of the seven known derivatives of CBD. It is created with the help of geranyl phosphate and divarinolic acid.
Although it has yet to become a pressing issue, CBDV, like all derivatives of CBD, is most likely to be considered federally legal provided it’s derived from a hemp plant containing less than .3% THC.
Given the limited research on CBDV, its potential effects are largely inferred from its relationship to CBD.
CBD is associated with a range of potential supportive qualities, such as promoting comfort, supporting a healthy inflammation response, and possibly aiding in mood balance. It’s important to emphasize that any potential attributes of CBDV are speculative based on the known characteristics of CBD.
